Organoids Market worth $12.20 Billion by 2030 - Exclusive Report by The Insight Partners
September 01, 2023 10:08 ET
|
The Insight Partners
Pune, India, Sept. 01, 2023 (GLOBE NEWSWIRE) -- An organoid is a miniaturized and simplified version of an organ fabricated in vitro in three dimensions that mimics the essential functional,...
Organoids Market (Source, Type) - Reach $8.12 Billion by 2028 at 21.8% CAGR with Intestine Segment Driving Growth During 2023–2028 | The Insight Partners
June 01, 2023 09:59 ET
|
The Insight Partners
Pune, India., June 01, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Organoids Market Size Report, Share, Revenue, Growth Strategy, Industry Trends and Forecast...
3D Cell Culture Market to hit USD 5.5 billion by 2032, says Global Market Insights Inc.
May 17, 2023 06:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, May 17, 2023 (GLOBE NEWSWIRE) -- 3D Cell Culture Market size is estimated to reach USD 5.5 billion by 2032, according to a new research report by Global Market Insights...
Rumi Scientific Announces Data Demonstrating Disease Modifying Effect of BRD9 Inhibition in a Huntington’s Disease Animal Model
April 26, 2023 07:05 ET
|
Rumi Scientific, Inc.
NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Rumi Scientific (“Rumi”), a developer of therapies for rare and neurodegenerative diseases discovered using its high throughput organoid phenotypic...
Rumi Scientific Appoints Allen A. Fienberg, Ph.D., as Chief Executive Officer and Chairman of the Board of Directors
March 30, 2023 08:00 ET
|
Rumi Scientific, Inc.
NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- Rumi Scientific (“Rumi”), a developer of therapies for rare and neurodegenerative diseases discovered using its high throughput organoid phenotypic...
BioMed X and AbbVie Extend Research Collaboration in the US
January 16, 2023 13:00 ET
|
BioMed X Institute
HEIDELBERG, Germany, Jan. 16, 2023 (GLOBE NEWSWIRE) -- BioMed X, an independent German biomedical research institute, announced today the extension of its ongoing research collaboration with AbbVie....
Organoids and Spheroids Market Is Expected to Reach $1.2 Billion by 2031: Allied Market Research
August 24, 2022 12:00 ET
|
Allied Market Research
Portland, OR, Aug. 24, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global organoids and spheroids market generated $516.6 million in 2021, and is...
Vyant Bio and OrganoTherapeutics Announce Strategic Collaboration to Discover Therapeutics to Treat Parkinson’s Disease
March 29, 2022 17:00 ET
|
Vyant Bio, Inc.
Cherry Hill, N.J. and Esch-sur-Alzette, Luxembourg, March 29, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an innovative biotechnology company reinventing drug...
Vyant Bio Reports Second Quarter 2021 Results and Provides Strategic Business Updates
August 16, 2021 16:01 ET
|
Vyant Bio, Inc.
Strategic Highlights Received an issued US Patent titled “High Throughput Optical Assay of Human Mixed Cell Population Spheroids” by the United States...
Pivotal Preclinical Oncology Platform Expands to Include New Patient-Derived Organoid Models
May 26, 2020 08:00 ET
|
Crown Bioscience
SAN DIEGO, May 26, 2020 (GLOBE NEWSWIRE) -- Crown Bioscience today announced the expansion of their unique organoid platform with the addition of 130 Hubrecht Organoid Technology (HUB)...